AbCellera Biologics (ABCL) Goodwill & Intangibles (2020 - 2025)
AbCellera Biologics' Goodwill & Intangibles history spans 6 years, with the latest figure at $87.1 million for Q3 2025.
- For the quarter ending Q3 2025, Goodwill & Intangibles fell 13.21% year-over-year to $87.1 million, compared with a TTM value of $87.1 million through Sep 2025, down 13.21%, and an annual FY2024 reading of $89.9 million, down 46.55% over the prior year.
- Goodwill & Intangibles for Q3 2025 was $87.1 million at AbCellera Biologics, down from $88.1 million in the prior quarter.
- The five-year high for Goodwill & Intangibles was $208.8 million in Q2 2022, with the low at $59.1 million in Q4 2021.
- Average Goodwill & Intangibles over 5 years is $146.5 million, with a median of $166.5 million recorded in 2024.
- Biggest YoY gain for Goodwill & Intangibles was 1057864.54% in 2021; the steepest drop was 59.7% in 2021.
- Tracing ABCL's Goodwill & Intangibles over 5 years: stood at $59.1 million in 2021, then soared by 203.37% to $179.3 million in 2022, then decreased by 6.18% to $168.2 million in 2023, then plummeted by 46.55% to $89.9 million in 2024, then dropped by 3.1% to $87.1 million in 2025.
- Per Business Quant, the three most recent readings for ABCL's Goodwill & Intangibles are $87.1 million (Q3 2025), $88.1 million (Q2 2025), and $89.0 million (Q1 2025).